Vitiligo and LXR-α Gene Polymorphism

Categories: BiologyScience

ABSTRACT

Vitiligo is an acquired skin disorder characterized by the selective destruction of melanocytes in the skin, resulting in the development of depigmented macules and patches. This study investigates the potential role of Liver X Receptor-α (LXR-α) gene polymorphism (rs2279238) (C>T) in vitiligo pathogenesis among Egyptian patients. We conducted genetic analysis on 25 vitiligo patients aged 12 to 50, comparing them with 25 age and sex-matched controls. The study revealed a significant association between LXR-α gene polymorphism and vitiligo in Egyptian patients. However, there was no correlation found between this polymorphism and the severity or activity of vitiligo.

These findings suggest that LXR-α gene polymorphism may play a role in the development of vitiligo among Egyptian patients.

KEY WORDS:

  • Vitiligo
  • Liver X Receptor alpha
  • Melanocytes
  • Gene polymorphism
  • Nuclear assay
  • Genotype
  • Allele

INTRODUCTION

Vitiligo is an acquired skin disorder resulting from the selective destruction of melanocytes in the skin, leading to the development of depigmented macules and patches[1]. It typically presents as bilaterally symmetric depigmented areas, with a preference for periorificial and trauma-prone skin regions.

Get quality help now
RhizMan
RhizMan
checked Verified writer

Proficient in: Biology

star star star star 4.9 (247)

“ Rhizman is absolutely amazing at what he does . I highly recommend him if you need an assignment done ”

avatar avatar avatar
+84 relevant experts are online
Hire writer

Commonly affected sites include the eyelids, ears, nostrils, perioral skin, axillae, wrists, elbows, hands, fingers, areolae, periumbilical skin, genitals, inguinal folds, ankles, knees, and toes[1].

Various theories have been proposed to elucidate the pathogenesis of vitiligo, including genetic, autoimmune, oxidative stress, autocytotoxic, neurohumoral, and convergence theories[2]. However, none of these theories has provided a comprehensive understanding of the disorder's development.

More than 150 genes have been identified that influence pigmentation in the skin, hair, and eyes, in addition to numerous signaling, transcriptional, and biological factors involved in regulatory pathways[3][4].

The focus of this study is the Liver X Receptor (LXR), a ligand-activated nuclear transcription factor that regulates the expression of genes involved in various physiological processes. LXR exists in two isoforms: LXR-α and LXR-β[5]. While LXR-α is highly expressed in metabolically active tissues such as the liver, adipose tissue, macrophages, and intestine, LXR-β is ubiquitously expressed in most tissues[5][6].

The relevance of LXR-α in vitiligo development arises from its functional link between keratinocytes and melanocytes. LXRs serve as transcription factors that regulate genes associated with lipid biosynthesis, immunity, and inflammation. Cutaneous LXRs are implicated in the regulation of melanocyte and keratinocyte functions[7][8].

Although melanocytes express LXR, the precise functions of LXR in these cells remain unclear. Kumar et al. noted a significant increase in LXR-α expression in melanocytes obtained from perilesional skin compared to normal skin in vitiligo patients[7].

MATERIALS AND METHODS

The study was conducted on a cohort of 25 vitiligo patients aged between 12 and 50, comprising both genders and encompassing various clinical types of vitiligo. Additionally, 25 age and sex-matched controls were included in the study.

Participants, both patients and controls, were recruited from the Dermatology Outpatient Clinic of Alexandria Main University Hospital in Egypt. Ethical approval for the study was granted by the institutional ethics committee, and all participants provided informed written consent.

Exclusion criteria were applied to eliminate individuals with the following conditions: inflammatory bowel disease, cancer, diabetes, polycystic ovary syndrome, obesity, and cardiovascular disease.

Study Assessments:

  1. Full History Taking: Comprehensive personal history, age of vitiligo onset, disease course and duration, family history, drug history, and exposure to ultraviolet rays (UVR) were recorded.
  2. Examination:
    • A) Full general examination was conducted to identify any signs of systemic diseases.
    • B) Wood's light and dermoscopic examination of lesional skin were performed.
    • C) Detailed dermatological examination was carried out to categorize the type and distribution of vitiligo according to the Bordeaux VGICC classification 2014 and consensus nomenclature[9].
    • D) Body mass index (BMI) was calculated, and blood pressure measurements were taken to exclude obese and hypertensive participants.
    • E) Assessment of vitiligo severity was determined using the Vitiligo Area Scoring Index (VASI)[10] and the Vitiligo Disease Activity Score (VIDA score)[11].
  3. Sampling: Peripheral blood samples were collected from both patients and healthy controls. Random blood glucose, total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglyceride levels were evaluated for all participants.
  4. Genotyping: Detection of Liver X Receptor-α gene polymorphism (rs2279238) (C>T) was performed using an allelic discrimination technique involving a fluorogenic 5' Nuclease assay[12].

Genotyping Procedure:

The genotyping process involved several steps:

  1. DNA Extraction: Genomic DNA was extracted from whole blood samples using the GeneJET Whole Blood Genomic DNA Mini Kit (Thermo Fisher Scientific, USA), following the manufacturer's protocol.
  2. Assessment of DNA Concentration and Purity: The extracted DNA samples were assessed for concentration and purity using the Nanodrop 2000/2000c spectrophotometer (Thermo Fisher Scientific, USA).
  3. 5' Nuclease Assay: Genotyping for Liver X Receptor-α gene polymorphism (rs2279238) was carried out using the 5' nuclease assay. Each PCR reaction mix included 10 μL of TaqMan® Universal PCR Master Mix (Thermo Fisher Scientific, USA), 1 μL of TaqMan® SNP Genotyping Assay 20x (Assay ID: C__15967384_10), and 20 ng of DNA per reaction. The volume was adjusted to 20 μL with DNAase-free water. Thermal cycling was performed using the Stratagene Mx3000P (Thermo Fisher Scientific, USA), involving an initial AmpliTaq Gold enzyme activation step at 95ºC for 10 minutes, followed by 45 cycles of denaturation at 95ºC for 15 seconds and annealing/extension at 60ºC for 1 minute.

RESULTS

The vitiligo group comprised 14 females (56%) and 11 males (44%), with a mean age of 32.68 ± 11.09 years. No statistically significant differences were observed between the patient and control groups concerning age and sex. Additional characteristics of both groups are summarized in Tables (1) and (2).

There were no statistically significant differences between the patients and the control group regarding Random Blood Glucose (RBG) (P=0.095), Triglycerides (TG) (P=0.355), Low-Density Lipoprotein (LDL) (P=0.072), and High-Density Lipoprotein (HDL) (P=0.725).

The genotype distribution of the LXR gene single nucleotide polymorphism (SNP) (rs2279238) in the vitiligo and control groups was consistent with Hardy-Weinberg equilibrium. Hardy-Weinberg Equilibrium is a genetic law that states that allele or genotype frequencies in a given population will remain constant from generation to generation in the absence of evolutionary events such as immigration, random mating, selection, and genetic flow.

The observed genotype frequencies, including the TT mutant genotype, the heterozygous SNP (CT) genotype, and the (CC) wild genotype, were in agreement with the Hardy-Weinberg equilibrium in the overall population (P=0.051).

Genotype Frequency:

The distribution of genotypes for the Liver X Receptor-alpha gene (rs2279238) among the vitiligo group was as follows: TT mutant genotype was detected in 2 cases (8%), the heterozygous SNP (CT) genotype in 20 cases (80%), and finally, the (CC) wild genotype in 3 cases (12%).

On the other hand, the distribution of genotypes for the Liver X Receptor-alpha gene (rs2279238) among the control group revealed that no one carried the (TT) mutant genotype, the heterozygous SNP (CT) genotype was detected in 14 controls (56%), and finally, the (CC) wild genotype was detected in 11 controls (44%).

A statistically significant difference was observed between the two groups with regard to the (rs2279238) genotype (P=0.014) (see Table 3).

There were no statistically significant differences between the three genotypes regarding smoking (P=0.060).

All cases carrying the homozygous wild group (TT) had generalized vitiligo, while in the SNP heterozygous group (CT), 15 cases had generalized vitiligo, and 5 cases had segmental vitiligo. Meanwhile, all cases carrying the (CC) mutant genotype had segmental vitiligo.

There were no statistically significant differences between the three genotypes regarding VIDA (P=0.615), VASI score (P=0.131), family history of vitiligo (P=0.336), UV radiation exposure (P=0.241), or psychological stress (P=0.009).

Allele Frequency:

The observed minor allele frequency (T) of (rs2279238) was detected in 48% of cases, while in controls, it was detected in 28%. Conversely, the frequency of the (C) allele was found in 52% of cases, while in controls, it was 72% (see Table 4).

There was a statistically significant increase in the minor allele (T) frequency of (rs2279238) in vitiligo patients compared to controls (P=0.039). The minor allele (T) was found to be associated with a statistically significant increased risk of vitiligo.

DISCUSSION

In this study, the Liver X Receptor-alpha gene polymorphism (rs2279238) adhered to Hardy-Weinberg equilibrium, which aligns with the findings of Agarwal S et al. (13). They also reported that Liver X receptor-α polymorphisms (rs11039155 and rs2279238) followed Hardy-Weinberg equilibrium and were associated with vitiligo susceptibility. However, this contradicts Rogers et al. (14), who suggested that one of the primary causes of deviation from Hardy-Weinberg equilibrium is the association of genetic polymorphisms with disease pathogenesis.

Statistically significant differences were observed between the vitiligo and control groups regarding the (rs2279238) genotype, which corroborates the results of Agarwal S et al. (13). They reported that Liver X Receptor-α polymorphisms (rs2279238) are associated with vitiligo susceptibility. These findings are consistent with studies by Bakry OA et al. (15), Hong I et al. (16), and Kumar et al. (17), all of which reported elevated LXR-α expression in melanocytes from perilesional skin compared to normal skin in vitiligo patients. Bakry OA et al. (18) also found that LXR activation induces keratinocyte differentiation and inhibits proliferation, affecting melanocyte growth and survival. Similarly, Lee CS et al. (19) reported that Liver X receptor activation inhibits melanogenesis.

Allele Frequency:

Regarding allele frequency, the observed minor allele frequency (T) of (rs2279238) was significantly higher in vitiligo patients (48%) compared to controls (28%). Conversely, the frequency of the (C) allele was more prevalent in cases (52%) than controls (72%). These findings are in line with Agarwal S et al. (13), who reported that Liver X Receptor-α polymorphisms (rs2279238) allele frequency is associated with vitiligo susceptibility. The minor allele (T) was found to be significantly linked to an increased risk of vitiligo, with an Odds ratio of 0.039.

There were no statistically significant differences between the three genotypes regarding family history of vitiligo (P=0.336), consistent with Hilding et al. (20), who found no association between LXR genotyping and family history of disease in a similar study on diabetes.

Regarding smoking, there were no statistically significant differences between the three genotypes (P=0.060). This differs from findings by Jung CG et al. (21), who reported clear induction of LXR mRNA and increased translocation after exposure to cigarette smoking. It also contrasts with Rigamonti E et al. (22), who demonstrated increased ABCA1 expression (both mRNA and protein levels) in human cells after cigarette smoking exposure, leading to liver X receptor (LXR) translocation and activation, which in turn increases ABCA1 gene expression. These conflicting results may be attributed to differences in nucleotide sequences and the study's ethnic groups.

Regarding ultraviolet radiation (UVR) exposure, there were no statistically significant differences between patients and controls (P=0.241). This aligns with Ken C. N. Chang (23), who demonstrated that LXR signaling is down-regulated in cell-based models of photoaging, such as UV-activated keratinocytes and tumor necrosis factor (TNF_ α ) activated dermal fibroblasts. Similarly, Marionnet et al. (24) reported that gene expression changes induced by daily ultraviolet light require chronic successive exposure and can be prevented by broad-spectrum sunscreen. However, this contradicts with Thomas L. Des Marais et al. (25), who observed global changes in gene expression and associated pathways in human keratinocytes exposed to UVR. It also contradicts with Zhang, X. et al. (26), who reported that solar simulated ultraviolet radiation induces global histone hypoacetylation in human keratinocytes, leading to alterations in transcription factors and stress response genes. Furthermore, Takeuchi, et al. (27) conducted a study illustrating that mitotic genes are transcriptionally upregulated in fibroblasts exposed to very low doses of UVR.

Regarding psychological stress, there was a statistically significant difference between the three genotypes (P=0.009). This is consistent with Marsland AL et al. (28), who reported that persistent stress is accompanied by an increase in cytokines, oxidative stress, reactive oxygen species (ROS), and reactive nitrogen species (RNS) production, all of which can interfere with the regulatory mechanisms of liver regeneration and the regulation of nuclear receptors (NRs), especially the liver X receptor. Similarly, Nguyen ET et al. (29) found a correlation between psychological stress and liver X receptor regulation.

CONCLUSION

This study sheds light on the potential role of Liver X Receptor-alpha gene polymorphism (rs2279238) in the pathogenesis of vitiligo among Egyptian patients. Several significant findings emerged from our investigation:

  1. Our study revealed that the distribution of the (rs2279238) genotype in vitiligo patients conformed to Hardy-Weinberg equilibrium, providing a strong foundation for our genetic analysis.
  2. We observed a statistically significant difference in the (rs2279238) genotype between vitiligo patients and control subjects. This suggests that this gene polymorphism may play a pivotal role in susceptibility to vitiligo.
  3. Allele frequency analysis demonstrated a significant increase in the minor allele (T) frequency of (rs2279238) among vitiligo patients compared to controls. This minor allele (T) was associated with an elevated risk of vitiligo.
  4. No significant associations were found between the three genotypes and various factors, including family history of vitiligo, smoking habits, ultraviolet radiation exposure, and psychological stress.

Our findings align with previous research, supporting the notion that Liver X Receptor-alpha gene polymorphism (rs2279238) may contribute to vitiligo susceptibility. However, further studies with larger sample sizes and diverse populations are needed to confirm our results and explore the mechanisms underlying this genetic association.

Understanding the genetic basis of vitiligo is essential for developing targeted therapies and interventions that could potentially mitigate the impact of this challenging skin disorder.

Updated: Jan 18, 2024
Cite this page

Vitiligo and LXR-α Gene Polymorphism. (2024, Jan 18). Retrieved from https://studymoose.com/document/vitiligo-and-lxr-gene-polymorphism

Live chat  with support 24/7

👋 Hi! I’m your smart assistant Amy!

Don’t know where to start? Type your requirements and I’ll connect you to an academic expert within 3 minutes.

get help with your assignment